Messenger RNA sequencing (mRNA-seq) has revolutionized the exploration of cellular functionality, offering researchers unparalleled insights into the transcriptional landscape of cells. By leveraging high-throughput and precise next-generation sequencing (NGS) techniques, RNA-seq unveils gene expression profiles and highlights the dynamic variations within the transcriptome. This innovative technique selectively captures or enriches single-stranded messenger RNAs (mRNAs), converting them into complementary DNA (cDNA) for streamlined library preparation.
At Novogene, we employ cutting-edge Illumina NovaSeq platforms for sequencing cDNA libraries. These platforms utilize a paired-end 150 bp sequencing strategy, providing high-quality short-read data. Leveraging our extensive experience and robust sequencing capacity, Novogene offers a diverse range of services to meet various research objectives. Our offerings extend beyond eukaryotic mRNA sequencing (mRNA-seq). Novogene can also deliver data on prokaryotic transcripts, non-coding RNAs, full-length isoforms (long-reads), whole transcriptomes, and meta-transcriptomes.
Discover the power of mRNA-seq with Novogene’s services, designed to assist in a variety of research goals:
Choose Novogene for mRNA-seq that not only meets but exceeds your expectations. Elevate your research with us.
Note: Sample amounts are listed for reference only. For detailed information, please contact us with your customized requests.
Note: Recommended data outputs and analysis contents displayed are for reference only. For detailed information, please contact us with your customized requests.
The project workflow at Novogene for mRNA-seq services begins with Sample Quality Control (Sample QC), ensuring that the provided samples meet the stringent criteria of the RNA-Seq technique. Following this, tailored libraries are meticulously crafted based on the target organism and application, with the library’s quality assessed through Library QC. Subsequently, a 150 bp paired-end sequencing strategy, employing Illumina PE150 technology, captures the essence of the samples. The resulting data undergoes thorough quality checks (Data QC), and our experienced bioinformaticians perform in-depth analyses to extract valuable insights. The culmination of this journey is the delivery of comprehensive, publication-ready results.
RNA-seq (mRNA-seq) is the most frequently cited NGS method. Here we have summarized some outstanding academic publications that used Novogene RNA sequencing (mRNA Sequencing) services.
DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs
Journal: CellIssue date: 2023.6IF: 64.5DOI: 10.1016/j.cell.2023.05.028
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
Journal: Nature MedicineIssue Date: 2023.5IF: 87.24DOI: 10.1038/s41591-023-02363-y
Constitutive GLI1 expression in chondrosarcoma is regulated by major vault protein via mTOR/S6K1 signaling cascade
Cell Death & DifferentiationIssue Date: 2021.2IF: 10.717DOI: 10.1038/s41418-021-00749-4
High-throughput screening in postimplantation haploid epiblast stem cells reveals Hs3st3b1 as a modulator for reprogramming
Stem Cells Translational MedicineIssue Date: 2021.1IF: 11.5DOI: 10.1002/sctm.20-0468
Mechanisms for the impacts of graphene oxide on the developmental toxicity and endocrine disruption induced by bisphenol A on zebrafish larvae
Journal of Hazardous MaterialsIssue Date: 2020.12IF: 9.038DOI: 10.1016/j.jhazmat.2020.124867
Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma
Genome MedicineIssue Date: 2020.11IF: 10.675DOI: 10.1186/s13073-020-00796-5
Relief of Biofilm Hypoxia Using an Oxygen Nanocarrier: A New Paradigm for Enhanced Antibiotic Therapy
Advanced scienceIssue Date: 2020.3IF: 15.84DOI: 10.1002/advs.202000398
The x-axis shows the base position along each sequencing read and the y-axis shows the base error rate.
The x-axis for reads position, the y-axis for single base percentage. Different color for different base type.
The x-axis represents the name of sample, the y-axis indicates the log10(FPKM+1), parameters of box plots are indicated, including maximum, upper quartile, mid-value, lower quartile and minimum.
The x-axis shows the fold change of genes in different samples. The y-axis shows the statistically significant degree of changes in gene expression levels. The smaller the corrected pvalue, the bigger -log10(corrected pvalue), the more significant the difference. The points represent genes, blue dots indicate no significant difference in gene expression, red dots indicate upregulated differentially expressed genes, green dots indicate downregulated differentially expressed genes.
The overall results of FPKM cluster analysis, clustered using the log10(FPKM+1) value. Red denotes genes with high expression levels, and blue denotes genes with low expression levels. The color ranging from red to blue indicates log10(FPKM+1) value from large to small.
The field is required.
I agree that Novogene Corporation may use this information to contact me to assist with my request. I understand that all personal information I have submitted will be kept confidential in accordance with Novogene's privacy policy.